EndoStim Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:EndoStim Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012912
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EndoStim Inc (EndoStim) is a medical device company that offers therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. EndoStim also conducts clinical research for various drugs. The company conducts research on common symptoms and causes of gastroesophageal reflux disease. It markets its products in domestic and international healthcare markets through its network of distributors. The company has presence in Europe, Asia, and Latin America. EndoStim is headquartered in Dallas, Texas, the US.

EndoStim Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EndoStim Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
EndoStim Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
EndoStim Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
EndoStim Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
EndoStim Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EndoStim Inc, Medical Equipment, Deal Details 10
Venture Financing 10
EndoStim Raises USD25 Million in Series D Financing 10
EndoStim Raises USD11 Million in Venture Financing 11
EndoStim Raises USD2.5 Million in Venture Financing 12
EndoStim Raises US$14 Million In Venture Financing 13
EndoStim Secures US$5.6 Million In Series B Venture Financing 14
Equity Offering 15
EndoStim Withdraws IPO for up to USD38.4 Million 15
EndoStim Inc – Key Competitors 16
EndoStim Inc – Key Employees 17
EndoStim Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO 19
Legal and Regulatory 20
Nov 30, 2016: EndoStim Opens its New Corporate Headquarters in Dallas 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
EndoStim Inc, Medical Equipment, Key Facts 2
EndoStim Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
EndoStim Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
EndoStim Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
EndoStim Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
EndoStim Inc, Deals By Market, 2011 to YTD 2017 8
EndoStim Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EndoStim Raises USD25 Million in Series D Financing 10
EndoStim Raises USD11 Million in Venture Financing 11
EndoStim Raises USD2.5 Million in Venture Financing 12
EndoStim Raises US$14 Million In Venture Financing 13
EndoStim Secures US$5.6 Million In Series B Venture Financing 14
EndoStim Withdraws IPO for up to USD38.4 Million 15
EndoStim Inc, Key Competitors 16
EndoStim Inc, Key Employees 17
EndoStim Inc, Other Locations 18

★海外企業調査レポート[EndoStim Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tokyo Electric Power Company Holdings Incorporated (9501):電力:M&Aディール及び事業提携情報
    Summary Tokyo Electric Power Company Holdings Incorporated (TEPCO) is an energy utility. It generates, transmits and distributes electricity; transports fuel; and retails electricity and gas. The company produces power using coal, gas, LNG, solar, wind and hydro sources. TEPCO has presence in the en …
  • Marathon Oil Corporation:戦略・SWOT・企業財務分析
    Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • Five Star Senior Living Inc (FVE):製薬・医療:M&Aディール及び事業提携情報
    Summary Five Star Senior Living Inc (Five Star), formerly Five Star Quality Care Inc is a healthcare service provider that offers senior living and patient care services. The center’s services include independent living, assisted living, skilled nursing care, memory care, dining and nutrition, hospi …
  • Telia Company (TELIA):企業の財務・戦略的SWOT分析
    Telia Company (TELIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Uelzena eG:企業の戦略・SWOT・財務情報
    Uelzena eG - Strategy, SWOT and Corporate Finance Report Summary Uelzena eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Seagate Technology Public Limited Company:企業のM&A・事業提携・投資動向
    Seagate Technology Public Limited Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seagate Technology Public Limited Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Marsulex Environmental Technologies Corp:企業の戦略的SWOT分析
    Marsulex Environmental Technologies Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Emera Inc:発電所・企業SWOT分析
    Emera Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Selecta Biosciences Inc (SELB):製薬・医療:M&Aディール及び事業提携情報
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Discovery Holdings Limited (DSY):企業の財務・戦略的SWOT分析
    Discovery Holdings Limited (DSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • New Sports Group Limited:企業のM&A・事業提携・投資動向
    New Sports Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Sports Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Tesson Holdings limited:戦略・SWOT・企業財務分析
    Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report Summary Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Flex Ltd.:企業の戦略・SWOT・財務分析
    Flex Ltd. - Strategy, SWOT and Corporate Finance Report Summary Flex Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Southern Company Gas:企業の戦略的SWOT分析
    Southern Company Gas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • H.I.G. Capital LLC:企業の戦略的SWOT分析
    H.I.G. Capital LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Gene Techno Science Co Ltd (4584):企業の財務・戦略的SWOT分析
    Summary Gene Techno Science Co Ltd (GTS) develops and markets drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological, biosimilar and regenerative medicine in the therapy areas of renal disease, immunological, oncology, ophthalmic, and bone related di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆